The Patent Finder

Cyclacel Limited

Also on record
Records under this name other than the patents Cyclacel Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Cyclacel Limited

PatentTitleStatus Expires Confidence
US 9,133,199Pyrimidine derivatives as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,563,542Pyrimidine derivatives as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,592,581Trisubstituted purine derivatives
Lapsed on the fee record
Ended Nov 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 26, 2025From the USPTO record
US 8,536,188Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
Lapsed on the fee record
Ended Sep 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 17, 2025From the USPTO record
US 8,497,291Crystalline pyrimidine nucleoside derivative suspensions in capsules
Lapsed on the fee record
Ended Jul 30, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 30, 2025From the USPTO record
US 9,675,631Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
Lapsed on the fee record
Ended Jun 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 13, 2025From the USPTO record
US 8,404,692Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds
Lapsed on the fee record
Ended Mar 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 26, 2025From the USPTO record
US 8,349,792Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent
Lapsed on the fee record
Ended Jan 8, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 8, 2025From the USPTO record
US 9,493,471Pyrimidine derivatives as protein kinase inhibitors
Lapsed on the fee record
Ended Nov 15, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 15, 2024From the USPTO record
US 7,582,642New Purine Derivatives
Formerly held
Term ended
Ended no later than May 11, 2024 · Medium confidence
Term endedEnded no later than May 11, 2024Medium confidence
10 of 53 patents shown.
Pro members see all 53.
Pro members: see all 53 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited